Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid Read More

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether Read More

Attempts to restrict pharmaceutical advertisements have failed many times over the years, often on First Amendment grounds.Read More